CEPI

The MERS coronavirus—MERS stands for “Middle East Respiratory Syndrome”—causes severe respiratory diseases with a high mortality rate. To date, there is neither a vaccine nor a specific treatment. The

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional

Joint vaccine development under the roof of the DZIF: Vaccine is currently being manufactured for use in clinical trials

A potential vaccine against SARS-CoV-2 is to undergo first clinical trials on

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths. These include the SARS coronavirus outbreak in 2002

Scientists and physicians at the German Center for Infection Research (DZIF) have been closely monitoring and investigating the development of the novel coronavirus SARS-CoV-2 since it first emerged

CEPI (the Coalition for Epidemic Preparedness Innovations) supports the development and manufacture of a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a zoonotic disease

The recent Ebola crisis has triggered global rethinking: the global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the international